Design, Screening and Development of Asymmetric siRNAs Targeting the <i>MYC</i> Oncogene in Triple-Negative Breast Cancer.

Biomol Ther (Seoul) · 2025 · PMC11704396 · PMID 39632755

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

This indicates an increasing trend in the knockdown efficacy of the modified siRNAs over time compared to that of their unmodified counterparts.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.